Pharmaceutical Temperature Controlled Packaging Solutions Market - Databook 2025 to 2034

The global pharmaceutical temperature controlled packaging solutionsmarket size was calculated at USD 5,950 million in 2024 and is predicted to attain around USD 11,600 million by 2034, expanding at a CAGR of 6.9% from 2025 to 2034.

Highlights of the Pharmaceutical Temperature Controlled Packaging Solutions Market

• North America held the largest share of the pharmaceutical temperature controlled packaging solutions market in 2024.
• Asia Pacific is anticipated to grow at the fastest rate in the market during the forecast period.
• By product, the reusable segment underwent notable growth in the pharmaceutical temperature controlled packaging solutions market in 2024.
• By product, the single-use solution segment is projected to experience the highest growth rate in the market between 2025 and 2034.
• By application, the temperature-sensitive pharmaceutical segment enjoyed a prominent position in the market during 2024.
• By application, the vaccines segment is anticipated to grow with the highest CAGR in the market during the studied years.

Industry Valuation and Growth Rate Projection

The pharmaceutical temperature controlled packaging solutions market refers to the production, distribution, and use of pharmaceutical temperature controlled packaging solutions, which a specialized packaging solutions designed to maintain a consistent temperature for sensitive products during transportation and storage. Temperature controlled packaging solutions improve security and traceability.

Rising demand for biopharmaceuticals is leading to the growth of the market. In January 2025, an innovative temperature-controlled packaging solution for the pharmaceutical industry was launched by DS Smith. TailorTemp was launched for the first time at PharmaPack Europe 2025 in Paris.

• In October 2024, the launch of Credo Vault, an advanced bulk shipper that offers thermal reliability and real-time monitoring for pharmaceutical and life sciences shipments, was announced by a global leader in temperature-controlled packaging, Peli Bio Thermal.

Pharmaceutical Temperature Controlled Packaging Solutions Market: Stats and Figures

• In December 2024, a provider of passive temperature-controlled containers, was expanded its global footprint following its recent acquisition by Cold Chain Technologies (CCT). This strategic integration creates an extensive network of temperature-controlled solutions to meet the increasing global demand for pharmaceutical and life sciences shipments. With the combined resources of CCT and Tower, customers now benefit from a highly expanded hub network with 3 Centers of Excellence and 54 regional hubs spanning 26 countries, allowing improved customer service and broader geographic coverage.

How AI has Benefitted the Market

• Internet of Things (IoT), along with artificial intelligence (AI) technologies, act as pharmaceutical security functions by measuring drug temperature sensitivity and identifying tampering incidents while notifying buyers and producers of danger situations. AI can play a significant role in packaging manufacturing quality control. It can scan packaging products at many stages of manufacturing processes and detect defects at a micro level that may be invisible to the human eye.
• Provide information: AI-based devices continuously monitor temperature and humidity levels of shipments during transit.
• Improve quality and safety: AI-based devices are transforming pharmaceutical packaging security, preventing counterfeiting, and improving drug safety with authentication and smart tracking.
• In manufacturing, AI in manufacturing improves quality control processes by employing machine learning and computer vision to identify defects in real time.

Industry Leader Announcements

• Sam Herbert as CEO of Peli Bio Thermal

Herbert expressed enthusiasm about the opportunity, “I am honored to join Peli Bio Thermal at such an exciting time. I have long admired Peli Bio Thermal’s track record of innovation as a customer, and I look forward to building on the company’s legacy of inventing solutions that safeguard therapies on their journey to the patients that need them. I would like to thank Kari for her impact during her tenure and her continued involvement as an adviser.”

• Mark Barakat, General Manager at Cryopak

In March 2023, a leader in cold chain packaging and temperature monitoring devices, Cryopak was expanded its environmentally friendly shipping solutions in collaboration with M. Chason & Son Inc. to form Chasen Fiber Technologies. Mark Barakat, General Manager at Cryopak, said, ‘This partnership is an important step in our overall corporate pledge to lead the cold chain packaging industry toward sustainability.’

Geographical Insights

North America held the largest share of the pharmaceutical temperature controlled packaging solutions market in 2024. Asia Pacific is anticipated to grow at the fastest rate in the market during the forecast period.

North America

North America held the largest share of the pharmaceutical temperature controlled packaging solutions market in 2024. High demand for clinical trials, drugs, and vaccines is driving the growth of the market in North America. The United States is the leading country for the growth of the market in North America.

• In September 2024, $365 million in infrastructure supporting the clinical and commercial scale final assembly and packaging of drug-device combination products using advanced drug delivery systems, with an emphasis on injectable formats, was invested by PCI Pharma Services.

Asia Pacific

Asia Pacific is anticipated to grow at the fastest rate in the market during the forecast period. India and China are the leading countries for the growth of the pharmaceutical temperature controlled packaging solutions market in the Asia Pacific region.

• In January 2025, a global manufacturing partner to the nutraceutical, pharmaceutical, and biotech markets, Lonza, expanded capsule manufacturing capacity at its sites in Rewari (IN) and Suzhou (CN).

Recent Developments:

• In March 2025, Cold Chain Technologies (CCT) acquired Global Cold Chain Solutions (GCCS). The combined entity will provide cold chain solutions to life sciences and pharmaceutical companies.
• In September 2023, the launch of two new temperature-controlled packaging solutions for the pharmaceutical industry, the Celsure VIP Multi-Use Parcel Shipper series and Celsure XL Pallet Shipper series, was announced by the phase change material (PCM) technology company Pluss Advanced Technologies (PLUSS).

Competitive Landscape

The pharmaceutical temperature controlled packaging market is highly competitive, with leading pharmaceutical companies like Pelican Biothermal and Cryopak holding the highest market share.

The market is dominated by many pharmaceutical companies for their significant contributions to improving quality and safety, and manufacturing. Based on the recent data, the top three companies leading are

• Company Name: Pelican Biothermal
• Year of Incorporation: 2003
• Headquarters: Avenue North, Maple Grove, Minnesota, United States.

Pelican Biothermal LLC offers a wide range of thermally protected, temperature-controlled packaging and services solutions to the global life science industry. The Pelican Biothermal LLC annual revenue was $44.6 million.

• Company Name: Cryopak
• Year of Incorporation: 1981
• Headquarters: Edison, New Jersey.

Cryopak designs and manufactures refrigerants and cold chain packaging solutions for temperature-sensitive pharmaceutical, biotech, and life sciences shipments. Cryopak’s revenue is in the range of $50 million to $100 million.

The annual revenue of the companies Pelican Biothermal and Cryopak was $44.6 million and $50 million, respectively.